Clinical Trial Update: A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effects of pevonedistat on QTc interval in participants with advanced solid tumors; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Neoplasm

Drugs mentioned

• Pevonedistat (pevonedistat)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Solid Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2023-03-28